Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia | Zendy

Jo﻿hann Steiner | Zendy; Martin Walter | Zendy; Wenzel Glanz | Zendy; Zoltán Sarnyai | Zendy; HansGert Bernstein | Zendy; Stefan Vielhaber | Zendy; Andrea Kästner | Zendy; Martin Skalej | Zendy; Wolfgang Jordan | Zendy; Kolja Schiltz | Zendy; Christine Klingbeil | Zendy; KlausPeter Wandinger | Zendy; Bernhard Bogerts | Zendy; Winfried Stoecker | Zendy

Open Access

Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia

Author(s) -

Johann Steiner,

Martin Walter,

Wenzel Glanz,

Zoltán Sarnyai,

HansGert Bernstein,

Stefan Vielhaber,

Andrea Kästner,

Martin Skalej,

Wolfgang Jordan,

Kolja Schiltz,

Christine Klingbeil,

KlausPeter Wandinger,

Bernhard Bogerts,

Winfried Stoecker

Publication year - 2013

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/2013.jamapsychiatry.86

Subject(s) - schizophrenia (object oriented programming) , glutamate receptor , nmda receptor , medicine , psychiatry , antibody , receptor , psychology , immunology

Evidence for symptomatic convergence of schizophrenia and N-methyl-D-aspartate glutamate receptor (NMDA-R) encephalitis highlights the need for an assessment of antibody prevalence and specificity for distinct disease mechanisms in patients with a diagnosis of schizophrenia among glutamatergic pathophysiologic abnormalities in psychiatric disorders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research